MedTrace Logo

Washed Microbiota Transplantation (WMT) for Chronic Kidney Disease (CKD)

NCT05838118 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-05-01

No results posted yet for this study

Summary

Wahsed microbiota transplantation (WMT) is a novel and promising therapeutic method for Chronic Kidney Disease (CKD). This clinical trail aims to evaluate the efficacy and safety of WMT in the treatment of CKD.

Conditions

Interventions

DRUG

Fecal Microbiota Transplantation

Biologically active human fecal fluid (donor stool) is provided in fluid form.

OTHER

Standard of Care for Chronic Kidney Disease

Patients accepted oral drug or dialytic therapy like they used to be to treat CKD.

Sponsors & Collaborators

  • The Second Hospital of Nanjing Medical University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-20
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05838118 on ClinicalTrials.gov